Use of Bisphosphonates and The Effect of Osteonecrosis of The Jaw – Review

Authors

  • Tejeswini Ramashetty Amarnath
  • Shashank Uniyal
  • Shilpi Joshi
  • Sony Jethani
  • Emmadi Mounika
  • Ajith Geevee

DOI:

https://doi.org/10.52783/jns.v14.2268

Keywords:

N/A

Abstract

Bisphosphonates are highly efficient antiresorptive drugs used to treat diseases with increased osteoclast activity such as cancer-related conditions, osteoporosis, multiple myeloma, Paget disease, osteosclerosis, and fibrous dysplasia. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is defined as a current or previous treatment with BPs that leads to an exposed bone or bone that can be probe through a fistula in the maxillofacial region that does not heal within eight weeks.

Downloads

Download data is not yet available.

References

Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC. Cellular and molecular mechanisms of action of bisphosphonates. Cancer. 2000 Jun 15;88(12 Suppl):2961-78.

Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone. 2007 Sep;41(3):318-20.

Otto S, Hafner S, Grötz KA. The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2009 Mar;67(3):589-92.

Yamazaki T, Yamori M, Ishizaki T, Asai K, Goto K, Takahashi K, Nakayama T, Bessho K. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg. 2012 Nov;41(11):1397-403.

Morag Y, Morag-Hezroni M, Jamadar DA, Ward BB, Jacobson JA, Zwetchkenbaum SR, Helman J. Bisphosphonate-related osteonecrosis of the jaw: a pictorial review. Radiographics. 2009 Nov;29(7):1971-84.

Store G, Larheim TA. Mandibular osteoradionecrosis: a comparison of computed tomography with panoramic radiography. Dentomaxillofac Radiol. 1999 Sep;28(5):295-300.

Bianchi SD, Scoletta M, Cassione FB, Migliaretti G, Mozzati M. Computerized tomographic findings in bisphosphonate-associated osteonecrosis of the jaw in patients with cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Aug;104(2):249-58.

Stockmann P, Hinkmann FM, Lell MM, Fenner M, Vairaktaris E, Neukam FW, Nkenke E. Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study. Clin Oral Investig. 2010 Jun;14(3):311-7.

Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006 May 16;144(10):753-61.

Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004 May;62(5):527-34.

Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition. J Am Dent Assoc. 2005 Dec;136(12):1675-81.

Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK. Teriparatide and osseous regeneration in the oral cavity. N Engl J Med. 2010 Dec 16;363(25):2396-40.

Harper RP, Fung E. Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg. 2007 Mar;65(3):573-80.

Lau AN, Adachi JD. Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol. Aug;36(8):1835-1844

Downloads

Published

2025-03-18

How to Cite

1.
Amarnath TR, Uniyal S, Joshi S, Jethani S, Mounika E, Geevee A. Use of Bisphosphonates and The Effect of Osteonecrosis of The Jaw – Review. J Neonatal Surg [Internet]. 2025 Mar. 18 [cited 2025 Dec. 14];14(6S):523-6. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/2268

Issue

Vol. 14 No. 6S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.